News and reflections from the world of AI

    December 21, 2023

    Looking back on 2023: A year of important milestones

    Dear customers, shareholders, and our team, As we stand at the threshold of a new year, I wanted to take a moment to review the events of 2023 and express my gratitude for your continued support and hard work that the team has done. It has been a year of important milestones for Aiforia as the first deployments of our clinical AI-solutions were kicked-off in key markets.
    Written by Aiforia
    October 20, 2023

    Aiforia initiates path to secure its first regulatory approval in the United States – application to the FDA anticipated in 2024

    Aiforia Technologies Plc, Press Release, October 20, 2023 at 10:00 a.m. EEST
    Written by Aiforia
    September 18, 2023

    Aiforia complies with applicable HIPAA regulations, enabling it to provide solutions to a broader range of customers in the US

    Aiforia Technologies Plc, Press Release, 18 September 2023 at 09:00 a.m. EEST
    Written by Aiforia
    July 5, 2023

    Aiforia and Orion collaborate to develop AI solutions for image analytics in drug research

    Aiforia Technologies Plc, Press Release, 05 July 2023 at 12:00 a.m. EEST
    Written by Aiforia
    June 29, 2023

    Aiforia signs a major deal with an Italian Regional Health Authority

    Aiforia Technologies Plc Inside information 29 June 2023 at 10:30 a.m. EEST
    Written by Aiforia
    May 24, 2023

    Faron Pharmaceuticals utilizes AI to perform spatial analysis in cancer drug development research

    In cancer patients, the immune system's ability to recognize and destroy cancer cells is often suppressed due to several factors. Cancer cells can evade detection by the immune system by expressing unique or altered proteins on their surface, making it difficult for the body to identify them as foreign. Some cancer cells can produce substances that inhibit the activity of immune cells or activate ...
    Written by Aiforia
    1 2 3 4 5